Pioneering Patient Care: Meet Mark Meyers, founder of NeuroDyne

Founder of NeuroDyne, Mark Meyers stands at the cusp of medical innovation with his company’s cutting-edge wearable seizure monitoring device. The startup’s flagship product is set to transform how seizures are managed, providing doctors with the ability to monitor their patients remotely.

The device, a cap worn by patients, wirelessly transmits brain activity data to physicians, offering an unprecedented level of insight into seizure activity. This technology not only detects seizures as they occur, but also provides neuro-markers for impending seizure events. Such predictive capabilities can dramatically enhance patient safety and care.

With the support of local industry leaders, NeuroDyne has immediate access to the Memphis market, which includes 

approximately 5,000 patients annually. Expanding to a regional scale across four states, the potential patient base grows to half a million.

But Mark isn’t going at it alone — Epicenter has been an avid supporter in the founder’s journey, helping NeuroDyne navigate the complex landscape of starting a biotech business.

“The Epicenter team provided extensive knowledge for our startup,”  Mark says, “including valuable insights, networking opportunities, and business guidance.”

NeuroDyne is also a graduate of Epicenter’s legacy ZeroTo510 Medical Device Accelerator, one of the most respected and competitive programs of its kind in the U.S. — it accepted less than 8% of all applicants.

NeuroDyne’s recent achievement of an NSF SBIR Phase II award is a testament to its potential. The company is now seeking private funding to unlock additional support from NSF SBIR Phase IIB and other statewide investment resources. This funding will be pivotal in transitioning from development to production, bringing this life-changing technology to patients and health care providers.

Celebrating 10 years in 2022, Epicenter’s ZeroTo510 medical device and health tech accelerator consistently ranked in the top 10 of accelerators in the country. The rigorous curriculum and access to deep industry expertise enabled startups to navigate the FDA regulatory process and ultimately compete in the regulated medical device and health tech marketplace. The program is now expanding its capabilities by focusing on identifying, starting, and fostering regional founders that will grow and develop the Memphis regional ecosystem.